EXPE
48
-13
CTAS
40
-5
MTCH
44
-2
WFC
68
7
DUK
74
-3
MTB
59
3
MMM
56
7
HOG
40
-5
NTAP
37
2
CRM
35
3
IPG
48
-5
ISRG
56
2
PLD
41
4
DVA
65
-3
COP
47
17
BRK.B
34
-4
HSIC
53
-6
MS
46
2
SLG
41
2
TXT
46
-2
EXPE
48
-13
CTAS
40
-5
MTCH
44
-2
WFC
68
7
DUK
74
-3
MTB
59
3
MMM
56
7
HOG
40
-5
NTAP
37
2
CRM
35
3
IPG
48
-5
ISRG
56
2
PLD
41
4
DVA
65
-3
COP
47
17
BRK.B
34
-4
HSIC
53
-6
MS
46
2
SLG
41
2
TXT
46
-2
Financhill
Back

Zoetis Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
7

ZTS
Zoetis

Last Price:
$160.65
Seasonality Move:
4.28%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.13
Seasonality Move:
6.73%
Sell
7
Zoetis (ZTS) is a Sell

Is Zoetis a Buy, Sell or Hold?

  • The current Zoetis [ZTS] share price is $161.68. The Score for ZTS is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • ZTS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZTS Stock Price Chart

What is Zoetis's stock price today?

  • The Zoetis share price today is $161.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZTS is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ZTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.61 Sell
Relative Strength Index (14 RSI): 42.26 Sell
Chaikin Money Flow: -790220 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (161.21 - 172.85) Sell
Bollinger Bands (100): (164.25 - 180.79) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

ZTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.3 Sell
20-day SMA: 165.52 Sell
50-day SMA: 166.79 Sell
200-day SMA: 176.99 Sell
8-day EMA: 165.81 Sell
20-day EMA: 166.33 Sell
50-day EMA: 168.14 Sell
200-day EMA: 174.38 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Zoetis Earnings Growth & ZTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.20 per share, and an increase next year of $0.75 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Zoetis Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):